跳至主要内容
临床试验/NCT02957643
NCT02957643已完成1 期

Treatment of Iron Defieciency Anemia

Hippocration General Hospital0 个研究点目标入组 50 人开始时间: 2016年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
50
主要终点
Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire

研究概览

简要总结

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

详细描述

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age more or equal of 18 years
  • Registration consent
  • Have complete 12h week of pregnancy
  • Hemoglobin levels <10,5 ptl
  • Hematocrit < 32 %

排除标准

  • Age <18 years
  • Absent registration consent
  • Step of pregnancy less than 12 weeks
  • Coadministration formulations iron oral or parenterally
  • Background of liver kirrosis
  • Background of aimosidirosis
  • Background acquired or chronic aimatochromatosis
  • Aplastic , Hemolytic anemia and chronic diseases
  • Chronic pancreatitis
  • Subjective renal or/and liver disease
  • Hypothyroidism or yperthyreoeidismos

研究组 & 干预措施

pregnant women

Placebo Comparator

iron dosage 1 per day for 3 months

干预措施: Iron (Drug)

pregnant women with anemia

Experimental

iron dosage 1 per day for 6 months

干预措施: Iron (Drug)

结局指标

主要结局

Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaire

时间窗: up to 24 months

Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant

次要结局

  • adverse reactions(up to 24 months)

研究者

发起方
Hippocration General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

ANGELOS DANIILIDIS

Assistant professor of obstetrics and gynaecology A.U.TH.

Hippocration General Hospital

相似试验